Vasorelaxant action of 17β-estradiol in rat uterine arteries: Role of nitric oxide synthases and estrogen receptors

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 293, Issue 6, 2007, Pages

  Scott, Pierre André ^a,b   Tremblay, André ^a,b   Brochu, Michèle ^a,b   St Louis, Jean ^a,b  

^a UNIVERSITY OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Estrogens; Pregnancy

Indexed keywords

ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; FULVESTRANT; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; TAMOXIFEN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY DIAMETER; ARTERY PERFUSION; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; FEMALE; HORMONE ACTION; HORMONE BINDING; MESENTERIC ARTERY; MYOGRAPHY; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT; RECEPTOR BINDING; UTERINE ARTERY; VASCULAR SMOOTH MUSCLE; VASODILATATION; WESTERN BLOTTING;

ANIMALS; ARTERIES; ENZYME INHIBITORS; ESTRADIOL; ESTROGEN ANTAGONISTS; FEMALE; MUSCLE, SMOOTH, VASCULAR; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ESTROGEN; TAMOXIFEN; UTERUS; VASODILATION; VASODILATOR AGENTS;

EID: 36849093542     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00736.2007     Document Type: Article

References (44)

1. Abraham GE, Odell WD, Swerdloff RS, Hopper K. Simultaneous radioimmunoassay of plasma FSH, LH, progesterone, 17-hydroxyprogesterone, and estradiol-17β during the menstrual cycle. J Clin Endocrinol Metab 34: 312-318, 1972.
2. Bjornstrom L, Sjoberg M. Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes. Mol Endocrinol 19: 833-842, 2005.
3. Bologa CG, Revankar CM, Young SM, Edwards BS, Arterburn JB, Kiselyov AS, Parker MA, Tkachenko SE, Savchuck NP, Sklar LA, Oprea TI, Prossnitz ER. Virtual and biomolecular screening converge on a selective agonist for GPR30. Nat Chem Biol 2: 207-212, 2006.
4. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
5. Bruce NW. The distribution of blood flow to the reproductive organs of rats near term. J Reprod Fertil 46: 359-362, 1976.
6. Bucci M, Roviezzo F, Cicala C, Pinto A, Cirino G. 17-β-Oestradiol-induced vasorelaxation in vitro is mediated by eNOS through hsp90 and akt/pkb dependent mechanism. Br J Pharmacol 135: 1695-1700, 2002.
7. 2+ mobilization. Circ Res 81: 885-892, 1997.
8. Chen DB, Jia S, King AG, Barker A, Li SM, Mata-Greenwood E, Zheng J, Magness RR. Global protein expression profiling underlines reciprocal regulation of caveolin 1 and endothelial nitric oxide synthase expression in ovariectomized sheep uterine artery by estrogen/progesterone replacement therapy. Biol Reprod 74: 832-838, 2006.
9. Chester AH, Jiang C, Borland JA, Yacoub MH, Collins P. Oestrogen relaxes human epicardial coronary arteries through non-endothelium-dependent mechanisms. Coron Artery Dis 6: 417-422, 1995.
10. Cipolla M, Osol G. Hypertrophic and hyperplastic effects of pregnancy on the rat uterine arterial wall. Am J Obstet Gynecol 171: 805-811, 1994.
11. Connor HE, Feniuk W. Role of endothelium in haemoglobin-induced contraction of dog basilar artery. Eur J Pharmacol 140: 105-108, 1987.
12. Filardo E, Quinn J, Pang Y, Graeber C, Shaw S, Dong J, Thomas P. Activation of the novel estrogen receptor G protein-coupled receptor 30 (GPR30) at the plasma membrane. Endocrinology 148: 3236-3245, 2007.
13. Filardo EJ, Graeber CT, Quinn JA, Resnick MB, Giri D, DeLellis RA, Steinhoff MM, Sabo E. Distribution of GPR30, a seven membrane-spanning estrogen receptor, in primary breast cancer and its association with clinicopathologic determinants of tumor progression. Clin Cancer Res 12: 6359-6366, 2006.
14. Filardo EJ, Quinn JA, Bland KI, Frackelton AR Jr. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol Endocrinol 14: 1649-1660, 2000.
15. Garland HO, Atherton JC, Baylis C, Morgan MRA, Milne CM. Hormone profiles for progesterone, oestradiol, prolactin, plasma renin activity, aldosterone and corticosterone during pregnancy and pseudopregnancy in two strains of rat: correlation with renal studies. J Endocrinol 113: 435-444, 1987.
16. Han G, Ma H, Chintala R, Miyake K, Fulton DJ, Barman SA, White RE. Nongenomic, endothelium-independent effects of estrogen on human coronary smooth muscle are mediated by type I (neuronal) NOS and PI3-kinase-Akt signaling. Am J Physiol Heart Circ Physiol 293: H314-H321, 2007.
17. 2 in porcine coronary artery. Circulation 91: 2619-2626, 1995.
18. Keung W, Vanhoutte PM, Man RY. Acute impairment of contractile responses by 17β-estradiol is cAMP and protein kinase G dependent in vascular smooth muscle cells of the porcine coronary arteries. Br J Pharmacol 144: 71-79, 2005.
19. Kuiper GG, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S, Gustafsson JA. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 138: 863-870, 1997.
20. Leiberman JR, Wiznitzer A, Glezerman M, Feldman B, Levy J, Sharoni Y. Estrogen and progesterone receptors in the uterine artery of rats during and after pregnancy. Eur J Obstet Gynecol Reprod Biol 51: 35-40, 1993.
21. Lindberg BS, Johansson ED, Nilsson BA. Plasma levels of nonconjugated oestrone, oestradiol-17β and oestriol during uncomplicated pregnancy. Acta Obstet Gynecol Scand Suppl 32: 21-36, 1974.
22. Magness RR, Rosenfeld CR. Local and systemic estradiol-17β: effects on uterine and systemic vasodilation. Am J Physiol Endocrinol Metab 256: E536-E542, 1989.
23. Magness RR, Shaw CE, Phernetton TM, Zheng J, Bird IM. Endothelial vasodilator production by uterine and systemic arteries. II. Pregnancy effects on NO synthase expression. Am J Physiol Heart Circ Physiol 272: H1730-H1740, 1997.
24. Massicotte G, St-Louis J, Parent A, Schiffrin EL. Decreased in vitro responses to vasoconstrictors during pregnancy in normotensive and spontaneously hypertensive rats. Can J Physiol Pharmacol 65: 2466-2471, 1987.
25. Mugge A, Riedel M, Barton M, Kuhn M, Lichtlen PR. Endothelium independent relaxation of human coronary arteries by 17β-oestradiol in vitro. Cardiovasc Res 27: 1939-1942, 1993.
26. Naderali EK, Walker AB, Doyle P, Williams G. Comparable vasorelaxant effects of 17α- and 17β-oestradiol on rat mesenteric resistance arteries: an action independent of the oestrogen receptor. Clin Sci (Lond) 97: 649-655, 1999.
27. Nelson SH, Steinsland OS, Wang Y, Yallampalli C, Dong YL, Sanchez JM. Increased nitric oxide synthase activity and expression in human uterine artery during pregnancy. Circ Res 87: 406-411, 2000.
28. Ni Y, Meyer M, Osol G. Gestation increases nitric oxide-mediated vasodilation in rat uterine arteries. Am J Obstet Gynecol 176: 856-864, 1997.
29. Revankar CM, Cimino DF, Sklar LA, Arterburn JB, Prossnitz ER. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 307: 1625-1630, 2005.
30. Revankar CM, Mitchell HD, Field AS, Burai R, Corona C, Ramesh C, Sklar LA, Arterburn JB, Prossnitz ER. Synthetic estrogen derivatives demonstrate the functionality of intracellular GPR30. ACS Chem Biol 2: 536-544, 2007.
31. Rosenfeld CR, Chen C, Roy T, Liu X. Estrogen selectively up-regulates eNOS and nNOS in reproductive arteries by transcriptional mechanisms. J Soc Gynecol Investig 10: 205-215, 2003.
32. Rosenfeld CR, Killam AP, Battaglia FC, Makowski EL, Meschia G. Effect of estradiol-17, on the magnitude and distribution of uterine blood flow in nonpregnant, oophorectomized ewes. Pediatr Res 7: 139-148, 1973.
33. Rosenfeld CR, White RE, Roy T, Cox BE. Calcium-activated potassium channels and nitric oxide coregulate estrogen-induced vasodilation. Am J Physiol Heart Circ Physiol 279: H319-H328, 2000.
34. Salas E, Lopez MG, Villarroya M, Sanchez-Garcia P, De PR, Dixon WR, Garcia AG. Endothelium-independent relaxation by 17-α-estradiol of pig coronary arteries. Eur J Pharmacol 258: 47-55, 1994.
35. Salhab WA, Shaul PW, Cox BE, Rosenfeld CR. Regulation of types I and III NOS in ovine uterine arteries by daily and acute estrogen exposure. Am J Physiol Heart Circ Physiol 278: H2134-H2142, 2000.
36. Schonfelder G, Fuhr N, Hadzidiakos D, John M, Hopp H, Paul M. Preeclampsia is associated with loss of neuronal nitric oxide synthase expression in vascular smooth muscle cells of the human umbilical cord. Histopathology 44: 116-128, 2004.
37. Shaw L, Taggart MJ, Austin C. Mechanisms of 17β-oestradiol induced vasodilatation in isolated pressurized rat small arteries. Br J Pharmacol 129: 555-565, 2000.
38. St-Louis J, Paré H, Roy B, Brochu M. Decreased response to vasopressin in the mesenteric resistance arteries of pregnant rats: effects of nifedipine and Bay K 8644. J Soc Gynecol Investig 2: 516-522, 1995.
39. St-Louis J, Paré H, Sicotte B, Brochu M. Increased reactivity of uterine arcuate artery throughout pregnancy and postpartum. Am J Physiol Heart Circ Physiol 273: H1148-H1153, 1997.
40. Sudhir K, Chou TM, Mullen WL, Hausmann D, Collins P, Yock PG, Chatterjee K. Mechanisms of estrogen-induced vasodilation: in vivo studies in canine coronary conductance and resistance arteries. J Am Coll Cardiol 26: 807-814, 1995.
41. + channels to relaxation induced by 17β-estradiol but not by progesterone in isolated rat mesenteric artery rings. J Cardiovasc Pharmacol 41: 4-13, 2003.
42. Vagnoni KE, Shaw CE, Phernetton TM, Meglin BM, Bird IM, Magness RR. Endothelial vasodilator production by uterine and systemic arteries. III. Ovarian and estrogen effects on NO synthase. Am J Physiol Heart Circ Physiol 275: H1845-H1856, 1998.
43. White RE. Estrogen and vascular function. Vascul Pharmacol 38: 73-80, 2002.
44. White RE, Darkow DJ, Lang JL. Estrogen relaxes coronary arteries by opening BKCa channels through a cGMP-dependent mechanism. Circ Res 77: 936-942, 1995.